AI assistant
ArcticZymes Technologies Earnings Release 2023
3538_rns_2023-08-10_2de2c4a3-19f2-4256-8639-517a625dea7f.pdf
Earnings Release
Open in viewerOpens in your device viewer
ArcticZymes Technologies launches AZtaq™ DNA Polymerase
Tromsø, Norway, 10th August 2023 – ArcticZymes Technologies ASA (OSE: AZT) launches AZtaq™ DNA Polymerase
ArcticZymes Technologies (AZT) today announces the launch of its new product, AZtaq™ DNA Polymerase. AZtaq™ is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications.
Launching the AZtaq™ is a natural expansion of the Company's molecular tools portfolio. Being an essential enzyme in PCR, the thermostable DNA polymerase plays a pivotal role and enables numerous applications within molecular diagnostics and research. The Company expects to see synergies with their existing products currently supporting PCR workflows. Being able to serve customers with a more complete enzyme offering will be an important driver for sales growth in the molecular tools business.
CSO, Darren Ellis said: "Taken by itself Taq polymerase is a relatively standard product; however, the larger picture is that we are delivering on our Molecular Tools strategy to provide a complete portfolio of enzymes towards the MDx market. Now for the very first time AZT can offer all enzymes to a complete viral diagnostics workflow comprising the new AZtaq™, the recently launched AZscript™, together with our existing proteinase, nucleases, and Cod UNG."
For more information, please contact:
ArcticZymes Technologies
Chairman of the Board, Marie Roskrow Tel: +44 (0) 7496 959 743
CFO, Børge Sørvoll Tel: +47 952 90187
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.
The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes Technologies under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents. For more information, please visit the website: www.arcticzymes.com.